Rafts and the battleships of defense: The multifaceted microdomains for positive and negative signals in immune cells

Immunology Letters

Volumn 130, Issue 1-2, 2010, Pages 2-12

  Szöor, Árpád ^a   Szöllosi, János ^a   Vereb, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Cellular immunity; Co receptors; Cytokine receptors; Downstream signaling; Humoral immunity; Immune receptors; Inflammation; Lipid rafts; Membrane microdomains; Phagocytosis; Raft targeting therapies

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; FAS ANTIGEN; FC RECEPTOR IIA; INTERLEUKIN 15; INTERLEUKIN 2; LAT PROTEIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; PROTEIN KINASE LCK; PROTEIN KINASE LYN; RAC1 PROTEIN;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BONE MARROW CELL; CELL COMPOSITION; CELL HETEROGENEITY; CELL SIZE; CELLULAR IMMUNITY; EUKARYOTIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIPID RAFT; LYMPHOCYTE FUNCTION; LYMPHOID CELL; MONOCYTE MACROPHAGE PRECURSOR CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPECTROSCOPY; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNITY; MEMBRANE MICRODOMAINS; SIGNAL TRANSDUCTION;

EID: 77950946913     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.016     Document Type: Review

References (185)

1. Singer S.J., Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 1972, 175:720-731.
2. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
3. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000, 1:31-39.
4. Brown R.E. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J Cell Sci 1998, 111(Pt 1):1-9.
5. Brown D.A., Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992, 68:533-544.
6. Schroeder R., London E., Brown D.A. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 1994, 91:12130-12134.
7. Brown D.A., London E. Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 1998, 164:103-114.
8. Dietrich C., Bagatolli L.A., Volovyk Z.N., Thompson N.L., Levi M., Jacobson K., et al. Lipid rafts reconstituted in model membranes. Biophys J 2001, 80:1417-1428.
9. Edidin M., Zuniga M.C., Sheetz M.P. Truncation mutants define and locate cytoplasmic barriers to lateral mobility of membrane glycoproteins. Proc Natl Acad Sci USA 1994, 91:3378-3382.
10. Vereb G., Matkó J., Vámosi G., Ibrahim S.M., Magyar E., Varga S., et al. Cholesterol-dependent clustering of IL-2Rα and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. Proc Natl Acad Sci USA 2000, 97:6013-6018.
11. Nagy P., Mátyus L., Jenei A., Panyi G., Varga S., Matkó J., et al. Cell fusion experiments reveal distinctly different association characteristics of cell-surface receptors. J Cell Sci 2001, 114:4063-4071.
12. Vereb G., Matkó J., Szöllosi J. Cytometry of fluorescence resonance energy transfer. Methods Cell Biol 2004, 75:105-152.
13. Biro A., Cervenak L., Balogh A., Lorincz A., Uray K., Horváth A., et al. Novel anti-cholesterol monoclonal immunoglobulin G antibodies as probes and potential modulators of membrane raft-dependent immune functions. J Lipid Res 2007, 48:19-29.
14. Gombos I., Steinbach G., Pomozi I., Balogh A., Vámosi G., Gansen A., et al. Some new faces of membrane microdomains: a complex confocal fluorescence, differential polarization, and FCS imaging study on live immune cells. Cytometry A 2008, 73:220-229.
15. Sharma P., Varma R., Sarasij R.C., Ira, Gousset K., Krishnamoorthy G., et al. Nanoscale organization of multiple GPI-anchored proteins in living cell membranes. Cell 2004, 116:577-589.
16. Kawasaki K., Yin J.J., Subczynski W.K., Hyde J.S., Kusumi A. Pulse EPR detection of lipid exchange between protein-rich raft and bulk domains in the membrane: methodology development and its application to studies of influenza viral membrane. Biophys J 2001, 80:738-748.
17. Lenne P.F., Wawrezinieck L., Conchonaud F., Wurtz O., Boned A., Guo X.J., et al. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. Embo J 2006, 25:3245-3256.
18. Eggeling C., Ringemann C., Medda R., Schwarzmann G., Sandhoff K., Polyakova S., et al. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 2009, 457:1159-1162.
19. Varma R., Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 1998, 394:798-801.
20. Pralle A., Keller P., Florin E.L., Simons K., Horber J.K. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 2000, 148:997-1008.
21. Kellner R.R., Baier C.J., Willig K.I., Hell S.W., Barrantes F.J. Nanoscale organization of nicotinic acetylcholine receptors revealed by stimulated emission depletion microscopy. Neuroscience 2007, 144:135-143.
22. Nagy P., Vereb G., Sebestyén Z., Horváth G., Lockett S.J., Damjanovich S., et al. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J Cell Sci 2002, 115:4251-4262.
23. Verveer P.J., Bastiaens P.I.H. Quantitative microscopy and systems biology: seeing the whole picture. Histochem Cell Biol 2008, 130:833-843.
24. Kenworthy A.K., Petranova N., Edidin M. High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 2000, 11:1645-1655.
25. Nicolau D.V., Burrage K., Parton R.G., Hancock J.F. Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane. Mol Cell Biol 2006, 26:313-323.
26. Harder T., Scheiffele P., Verkade P., Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998, 141:929-942.
27. Pyenta P.S., Holowka D., Baird B. Cross-correlation analysis of inner-leaflet-anchored green fluorescent protein co-redistributed with IgE receptors and outer leaflet lipid raft components. Biophys J 2001, 80:2120-2132.
28. Kusumi A., Nakada C., Ritchie K., Murase K., Suzuki K., Murakoshi H., et al. Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules. Annu Rev Biophys Biomol Struct 2005, 34:351-378.
29. Hancock J.F. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 2006, 7:456-462.
30. Vereb G., Szöllosi J., Matkó J., Nagy P., Farkas T., Vígh L., et al. Dynamic, yet structured: the cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci USA 2003, 100:8053-8058.
31. Douglass A.D., Vale R.D. Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 2005, 121:937-950.
32. Hořejší V., Zhang W., Schraven B. Transmembrane adaptor proteins: organizers of immunoreceptor signalling. Nat Rev Immunol 2004, 4:603-616.
33. Jacobson K., Mouritsen O.G., Anderson R.G.W. Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 2007, 9:7-14.
34. Parton R.G., Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007, 8:185-194.
35. Vassilieva E.V., Ivanov A.I., Nusrat A. Flotillin-1 stabilizes caveolin-1 in intestinal epithelial cells. Biochem Biophys Res Commun 2009, 379:460-465.
36. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 2000, 275:17221-17224.
37. Sheriff A., Gaipl U.S., Franz S., Heyder P., Voll R.E., Kalden J.R., et al. Loss of GM1 surface expression precedes annexin V-phycoerythrin binding of neutrophils undergoing spontaneous apoptosis during in vitro aging. Cytometry A 2004, 62:75-80.
38. Kiss E., Nagy P., Balogh A., Szöllosi J., Matkó J. Cytometry of raft and caveola membrane microdomains: from flow and imaging techniques to high throughput screening assays. Cytometry A 2008, 73:599-614.
39. McEver R.P. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002, 14:581-586.
40. Norman K.E., Moore K.L., McEver R.P., Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 1995, 86:4417-4421.
41. Sperandio M., Smith M.L., Forlow S.B., Olson T.S., Xia L., McEver R.P., et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 2003, 197:1355-1363.
42. Abbal C., Lambelet M., Bertaggia D., Gerbex C., Martinez M., Arcaro A., et al. Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood 2006, 108:3352-3359.
43. Borregaard N., Kjeldsen L., Lollike K., Sengelov H. Granules and secretory vesicles of the human neutrophil. Clin Exp Immunol 1995, 101(Suppl 1):6-9.
44. Stewart G.W. Stomatin. Int J Biochem Cell Biol 1997, 29:271-274.
45. Wang Y., Morrow J.S. Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem 2000, 275:8062-8071.
46. Feuk-Lagerstedt E., Samuelsson M., Mosgoeller W., Movitz C., Rosqvist A., Bergstrom J., et al. The presence of stomatin in detergent-insoluble domains of neutrophil granule membranes. J Leukoc Biol 2002, 72:970-977.
47. Quinn M.T., Gauss K.A. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J Leukoc Biol 2004, 76:760-781.
48. Shao D., Segal A.W., Dekker L.V. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 2003, 550:101-106.
49. Remijsen Q., Vanden Berghe T., Parthoens E., Asselbergh B., Vandenabeele P., Willems J. Inhibition of spontaneous neutrophil apoptosis by parabutoporin acts independently of NADPH oxidase inhibition but by lipid raft-dependent stimulation of Akt. J Leukoc Biol 2009, 85:497-507.
50. Scheel-Toellner D., Wang K., Assi L.K., Webb P.R., Craddock R.M., Salmon M., et al. Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem Soc Trans 2004, 32:679-681.
51. Dransfield I., Buckle A.M., Savill J.S., McDowall A., Haslett C., Hogg N. Neutrophil apoptosis is associated with a reduction in CD16 (FcγRIII) expression. J Immunol 1994, 153:1254-1263.
52. Bournazos S., Hart S.P., Chamberlain L.H., Glennie M.J., Dransfield I. Association of FcγRIIa (CD32a) with lipid rafts regulates ligand binding activity. J Immunol 2009, 182:8026-8036.
53. Metz M., Siebenhaar F., Maurer M. Mast cell functions in the innate skin immune system. Immunobiology 2008, 213:251-260.
54. Crivellato E., Ribatti D., Mallardi F., Beltrami C.A. The mast cell: a multifunctional effector cell. Adv Clin Path 2003, 7:13-26.
55. Dvorak A.M. Ultrastructural studies of human basophils and mast cells. J Histochem Cytochem 2005, 53:1043-1070.
56. von Bubnoff D., Novak N., Kraft S., Bieber T. The central role of Fce{open}RI in allergy. Clin Exp Dermatol 2003, 28:184-187.
57. Bolen J.B., Brugge J.S. Leukocyte protein tyrosine kinases: potential targets for drug discovery. Annu Rev Immunol 1997, 15:371-404.
58. Sheets E.D., Holowka D., Baird B. Membrane organization in immunoglobulin E receptor signaling. Curr Opin Chem Biol 1999, 3:95-99.
59. Kinet J.P., Quarto R., Perez-Montfort R., Metzger H. Noncovalently and covalently bound lipid on the receptor for immunoglobulin E. Biochemistry 1985, 24:7342-7348.
60. Holowka D., Sheets E.D., Baird B. Interactions between Fce{open}RI and lipid raft components are regulated by the actin cytoskeleton. J Cell Sci 2000, 113(Pt 6):1009-1019.
61. Field K.A., Apgar J.R., Hong-Geller E., Siraganian R.P., Baird B., Holowka D. Mutant RBL mast cells defective in Fce{open}RI signaling and lipid raft biosynthesis are reconstituted by activated Rho-family GTPases. Mol Biol Cell 2000, 11:3661-3673.
62. Freemont P.S. RING for destruction?. Curr Biol 2000, 10:R84-R87.
63. Lafont F., Simons K. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc Natl Acad Sci USA 2001, 98:3180-3184.
64. Oliver C., Fujimura A., Silveira E.S.A.M., Orlandini de Castro R., Siraganian R.P., Jamur M.C. Mast cell-specific gangliosides and Fce{open}RI follow the same endocytic pathway from lipid rafts in RBL-2H3 cells. J Histochem Cytochem 2007, 55:315-325.
65. Gombos I., Bacsó Z., Detre C., Nagy H., Goda K., Andrásfalvy M., et al. Cholesterol sensitivity of detergent resistance: a rapid flow cytometric test for detecting constitutive or induced raft association of membrane proteins. Cytometry A 2004, 61:117-126.
66. Davey A.M., Walvick R.P., Liu Y.X., Heikal A.A., Sheets E.D. Membrane order and molecular dynamics associated with IgE receptor cross-linking in mast cells. Biophys J 2007, 92:343-355.
67. Surviladze Z., Harrison K.A., Murphy R.C., Wilson B.S. FcepsilonRI and Thy-1 domains have unique protein and lipid compositions. J Lipid Res 2007, 48:1325-1335.
68. van Zanten T.S., Cambi A., Koopman M., Joosten B., Figdor C.G., Garcia-Parajo M.F. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci USA 2009.
69. Kitchens R.L. Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 2000, 74:61-82.
70. Tapping R.I., Tobias P.S. Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem Immunol 2000, 74:108-121.
71. van Putten J.P., Bouwman L.I., de Zoete M.R. Unraveling bacterial interactions with Toll-like receptors. Immunol Lett 2009.
72. Moreno-Altamirano M.M., Aguilar-Carmona I., Sanchez-Garcia F.J. Expression of GM1, a marker of lipid rafts, defines two subsets of human monocytes with differential endocytic capacity and lipopolysaccharide responsiveness. Immunology 2007, 120:536-543.
73. Tobias P.S., Soldau K., Ulevitch R.J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986, 164:777-793.
74. Pfeiffer A., Bottcher A., Orso E., Kapinsky M., Nagy P., Bodnár A., et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 2001, 31:3153-3164.
75. Wolf Z., Orso E., Werner T., Klunemann H.H., Schmitz G. Monocyte cholesterol homeostasis correlates with the presence of detergent resistant membrane microdomains. Cytometry A 2007, 71:486-494.
76. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002, 115:2603-2611.
77. Cuschieri J., Umanskiy K., Solomkin J. PKCζ is essential for endotoxin-induced macrophage activation. J Surg Res 2004, 121:76-83.
78. Leon-Ponte M., Kirchhof M.G., Sun T., Stephens T., Singh B., Sandhu S., et al. Polycationic lipids inhibit the pro-inflammatory response to LPS. Immunol Lett 2005, 96:73-83.
79. Wang R., Kovalchin J.T., Muhlenkamp P., Chandawarkar R.Y. Exogenous heat shock protein 70 binds macrophage lipid raft microdomain and stimulates phagocytosis, processing, and MHC-II presentation of antigens. Blood 2006, 107:1636-1642.
80. Jackson S.K., Abate W., Parton J., Jones S., Harwood J.L. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J Leukoc Biol 2008, 84:86-92.
81. Hermann C., Spreitzer I., Schroder N.W., Morath S., Lehner M.D., Fischer W., et al. Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFNγ release. Eur J Immunol 2002, 32:541-551.
82. Triantafilou M., Manukyan M., Mackie A., Morath S., Hartung T., Heine H., et al. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J Biol Chem 2004, 279:40882-40889.
83. Jones B.W., Heldwein K.A., Means T.K., Saukkonen J.J., Fenton M.J. Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages. Ann Rheum Dis 2001, 60(Suppl 3):iii6-iii12.
84. Beekman J.M., van der Linden J.A., van de Winkel J.G., Leusen J.H. FcγRI (CD64) resides constitutively in lipid rafts. Immunol Lett 2008, 116:149-155.
85. Tóth B., Garabuczi E., Sarang Z., Vereb G., Vámosi G., Aeschlimann D., et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol 2009, 182:2084-2092.
86. Tóth B., Sarang Z., Vereb G., Zhang A., Tanaka S., Melino G., et al. Over-expression of integrin β3 can partially overcome the defect of integrin β3 signaling in transglutaminase 2 null macrophages. Immunol Lett 2009, 126:22-28.
87. Grandl M., Bared S.M., Liebisch G., Werner T., Barlage S., Schmitz G. E-LDL and Ox-LDL differentially regulate ceramide and cholesterol raft microdomains in human Macrophages. Cytometry A 2006, 69:189-191.
88. Caparros E., Munoz P., Sierra-Filardi E., Serrano-Gomez D., Puig-Kroger A., Rodriguez-Fernandez J.L., et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006, 107:3950-3958.
89. Meyer zum Bueschenfelde C.O., Unternaehrer J., Mellman I., Bottomly K. Regulated recruitment of MHC class II and costimulatory molecules to lipid rafts in dendritic cells. J Immunol 2004, 173:6119-6124.
90. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
91. Burns S., Thrasher A.J., Blundell M.P., Machesky L., Jones G.E. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 2001, 98:1142-1149.
92. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., et al. Toll-like receptor 2-mediated NFκB activation requires a Rac1-dependent pathway. Nat Immunol 2000, 1:533-540.
93. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999, 285:221-227.
94. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000, 1:156-162.
95. Eren E., Yates J., Cwynarski K., Preston S., Dong R., Germain C., et al. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation. Scand J Immunol 2006, 63:7-16.
96. Hořejší V. The roles of membrane microdomains (rafts) in T cell activation. Immunol Rev 2003, 191:148-164.
97. Hořejší V. Lipid rafts and their roles in T-cell activation. Microbes Infect 2005, 7:310-316.
98. Lee K.H., Holdorf A.D., Dustin M.L., Chan A.C., Allen P.M., Shaw A.S. T cell receptor signaling precedes immunological synapse formation. Science 2002, 295:1539-1542.
99. Depoil D., Zaru R., Guiraud M., Chauveau A., Harriague J., Bismuth G., et al. Immunological synapses are versatile structures enabling selective T cell polarization. Immunity 2005, 22:185-194.
100. Bernard A., Boumsell L., Reinherz E.L., Nadler L.M., Ritz J., Coppin H., et al. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood 1981, 57:1105-1110.
101. Thoenes G., Soudais C., le Deist F., Griscelli C., Fischer A., Lisowska-Grospierre B. Structural analysis of low TCR-CD3 complex expression in T cells of an immunodeficient patient. J Biol Chem 1992, 267:487-493.
102. Chae W.J., Lee H.K., Han J.H., Kim S.W., Bothwell A.L., Morio T., et al. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor ζ chain ITAMs and their tyrosine residues. Int Immunol 2004, 16:1225-1236.
103. Straus D.B., Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992, 70:585-593.
104. Lowin-Kropf B., Shapiro V.S., Weiss A. Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism. J Cell Biol 1998, 140:861-871.
105. Wong J., Straus D., Chan A.C. Genetic evidence of a role for Lck in T-cell receptor function independent or downstream of ZAP-70/Syk protein tyrosine kinases. Mol Cell Biol 1998, 18:2855-2866.
106. Neumeister E.N., Zhu Y., Richard S., Terhorst C., Chan A.C., Shaw A.S. Binding of ZAP-70 to phosphorylated T-cell receptor ζ and η enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol Cell Biol 1995, 15:3171-3178.
107. James J.R., White S.S., Clarke R.W., Johansen A.M., Dunne P.D., Sleep D.L., et al. Single-molecule level analysis of the subunit composition of the T cell receptor on live T cells. Proc Natl Acad Sci USA 2007, 104:17662-17667.
108. Shimada Y., Inomata M., Suzuki H., Hayashi M., Waheed A.A., Ohno-Iwashita Y. Separation of a cholesterol-enriched microdomain involved in T-cell signal transduction. Febs J 2005, 272:5454-5463.
109. Chentouf M., Ghannam S., Bes C., Troadec S., Cerutti M., Chardes T. Recombinant anti-CD4 antibody 13B8.2 blocks membrane-proximal events by excluding the Zap70 molecule and downstream targets SLP-76, PLCγ1, and Vav-1 from the CD4-segregated Brij 98 detergent-resistant raft domains. J Immunol 2007, 179:409-420.
110. Kusumi A., Ike H., Nakada C., Murase K., Fujiwara T. Single-molecule tracking of membrane molecules: plasma membrane compartmentalization and dynamic assembly of raft-philic signaling molecules. Semin Immunol 2005, 17:3-21.
111. Harder T., Kuhn M. Selective accumulation of raft-associated membrane protein LAT in T cell receptor signaling assemblies. J Cell Biol 2000, 151:199-208.
112. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998, 8:723-732.
113. Pizzo P., Giurisato E., Tassi M., Benedetti A., Pozzan T., Viola A. Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur J Immunol 2002, 32:3082-3091.
114. Hořejší V. Transmembrane adaptor proteins in membrane microdomains: important regulators of immunoreceptor signaling. Immunol Lett 2004, 92:43-49.
115. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998, 92:83-92.
116. Yamasaki S., Nishida K., Hibi M., Sakuma M., Shiina R., Takeuchi A., et al. Docking protein Gab2 is phosphorylated by ZAP-70 and negatively regulates T cell receptor signaling by recruitment of inhibitory molecules. J Biol Chem 2001, 276:45175-45183.
117. Malissen B., Aguado E., Malissen M. Role of the LAT adaptor in T-cell development and Th2 differentiation. Adv Immunol 2005, 87:1-25.
118. Hundt M., Tabata H., Jeon M.S., Hayashi K., Tanaka Y., Krishna R., et al. Impaired activation and localization of LAT in anergic T cells as a consequence of a selective palmitoylation defect. Immunity 2006, 24:513-522.
119. Vang T., Abrahamsen H., Myklebust S., Hořejší V., Tasken K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J Biol Chem 2003, 278:17597-17600.
120. Davidson D., Bakinowski M., Thomas M.L., Hořejší V., Veillette A. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 2003, 23:2017-2028.
121. Furukawa T., Itoh M., Krueger N.X., Streuli M., Saito H. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 ζ chain. Proc Natl Acad Sci USA 1994, 91:10928-10932.
122. D'Oro U., Ashwell J.D. Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J Immunol 1999, 162:1879-1883.
123. Rodgers W., Rose J.K. Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains. J Cell Biol 1996, 135:1515-1523.
124. Edmonds S.D., Ostergaard H.L. Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes. J Immunol 2002, 169:5036-5042.
125. Brdičkova N., Brdička T., Angelisová P., Horváth O., Špička J., Hilgert I., et al. LIME: a new membrane Raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling. J Exp Med 2003, 198:1453-1462.
126. Saeki K., Fukuyama S., Ayada T., Nakaya M., Aki D., Takaesu G., et al. A major lipid raft protein raftlin modulates T cell receptor signaling and enhances Th17-mediated autoimmune responses. J Immunol 2009, 182:5929-5937.
127. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993, 11:191-212.
128. Martin M., Schneider H., Azouz A., Rudd C.E. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001, 194:1675-1681.
129. Kovacs B., Parry R.V., Ma Z., Fan E., Shivers D.K., Freiberg B.A., et al. Ligation of CD28 by its natural ligand CD86 in the absence of TCR stimulation induces lipid raft polarization in human CD4 T cells. J Immunol 2005, 175:7848-7854.
130. Round J.L., Tomassian T., Zhang M., Patel V., Schoenberger S.P., Miceli M.C. Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft aggregation, and effector function in T cells. J Exp Med 2005, 201:419-430.
131. Tavano R., Contento R.L., Baranda S.J., Soligo M., Tuosto L., Manes S., et al. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat Cell Biol 2006, 8:1270-1276.
132. Chuang Y.T., Fang L.W., Lin-Feng M.H., Chen R.H., Lai M.Z. The tumor suppressor death-associated protein kinase targets to TCR-stimulated NFκB activation. J Immunol 2008, 180:3238-3249.
133. Sebald A., Mattioli I., Schmitz M.L. T cell receptor-induced lipid raft recruitment of the IκB kinase complex is necessary and sufficient for NFκB activation occurring in the cytosol. Eur J Immunol 2005, 35:318-325.
134. Panyi G., Vámosi G., Bacsó Z., Bagdány M., Bodnár A., Varga Z., et al. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc Natl Acad Sci USA 2004, 101:1285-1290.
135. Tóth Á., Szilágyi O., Krasznai Z., Panyi G., Hajdu P. Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse. Immunol Lett 2009, 125:15-21.
136. Panyi G., Possani L.D., Rodriguez de la Vega R.C., Gáspár R., Varga Z. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des 2006, 12:2199-2220.
137. Zech T., Ejsing C.S., Gaus K., de Wet B., Shevchenko A., Simons K., et al. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. Embo J 2009, 28:466-476.
138. Drbal K., Moertelmaier M., Holzhauser C., Muhammad A., Fuertbauer E., Howorka S., et al. Single-molecule microscopy reveals heterogeneous dynamics of lipid raft components upon TCR engagement. Int Immunol 2007, 19:675-684.
139. + T cell. Int Immunol 2006, 18:951-957.
140. Gordon J., MacLean L.D. A lymphocyte-stimulating factor produced in vitro. Nature 1965, 208:795-796.
141. Nakamura Y., Russell S.M., Mess S.A., Friedmann M., Erdos M., Francois C., et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994, 369:330-333.
142. Damjanovich S., Bene L., Matkó J., Alileche A., Goldman C.K., Sharrow S., et al. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15: a fluorescence resonance energy transfer study. Proc Natl Acad Sci USA 1997, 94:13134-13139.
143. Vámosi G., Bodnár A., Vereb G., Jenei A., Goldman C.K., Langowski J., et al. IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci USA 2004, 101:11082-11087.
144. Matkó J., Bodnár A., Vereb G., Bene L., Vámosi G., Szentesi G., et al. GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines. Eur J Biochem 2002, 269:1199-1208.
145. Goebel J., Forrest K., Morford L., Roszman T.L. Differential localization of IL-2- and -15 receptor chains in membrane rafts of human T cells. J Leukoc Biol 2002, 72:199-206.
146. Bodnár A., Nizsalóczki E., Mocsár G., Szalóki N., Waldmann T.A., Damjanovich S., et al. A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions. Immunol Lett 2008, 116:117-125.
147. Stonier S.W., Schluns K.S. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett 2009.
148. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001, 14:105-110.
149. + intestinal intraepithelial lymphocytes. J Immunol 1999, 162:1896-1903.
150. + T cells deficient in the IL-15 receptor α chain. J Immunol 2002, 168:705-712.
151. Cambier J.C., Getahun A. B cell activation versus anergy; the antigen receptor as a molecular switch. Immunol Lett 2009.
152. Monroe J.G. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 2006, 6:283-294.
153. Cheng A.M., Rowley B., Pao W., Hayday A., Bolen J.B., Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995, 378:303-306.
154. Reth M., Brummer T. Feedback regulation of lymphocyte signalling. Nat Rev Immunol 2004, 4:269-277.
155. Dykstra M., Cherukuri A., Sohn H.W., Tzeng S.J., Pierce S.K. Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol 2003, 21:457-481.
156. Gupta N., Wollscheid B., Watts J.D., Scheer B., Aebersold R., DeFranco A.L. Quantitative proteomic analysis of B cell lipid rafts reveals that ezrin regulates antigen receptor-mediated lipid raft dynamics. Nat Immunol 2006, 7:625-633.
157. Mutch C.M., Sanyal R., Unruh T.L., Grigoriou L., Zhu M., Zhang W., et al. Activation-induced endocytosis of the raft-associated transmembrane adaptor protein LAB/NTAL in B lymphocytes: evidence for a role in internalization of the B cell receptor. Int Immunol 2007, 19:19-30.
158. Ohtsuka M., Arase H., Takeuchi A., Yamasaki S., Shiina R., Suenaga T., et al. NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling. Proc Natl Acad Sci USA 2004, 101:8126-8131.
159. Samardzic T., Gerlach J., Muller K., Marinkovic D., Hess J., Nitschke L., et al. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur J Immunol 2002, 32:2481-2489.
160. Trescol-Biemont M.C., Verschelde C., Cottalorda A., Bonnefoy-Berard N. Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Biochimie 2004, 86:287-294.
161. Su T.T., Guo B., Kawakami Y., Sommer K., Chae K., Humphries L.A., et al. PKCβ controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 2002, 3:780-786.
162. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 2005, 17:237-243.
163. Cherukuri A., Shoham T., Sohn H.W., Levy S., Brooks S., Carter R., et al. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol 2004, 172:370-380.
164. Wang Y., Brooks S.R., Li X., Anzelon A.N., Rickert R.C., Carter R.H. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002, 17:501-514.
165. Li H., Ayer L.M., Lytton J., Deans J.P. Store-operated cation entry mediated by CD20 in membrane rafts. J Biol Chem 2003, 278:42427-42434.
166. Szöllosi J., Hořejší V., Bene L., Angelisová P., Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 1996, 157:2939-2946.
167. Cherukuri A., Carter R.H., Brooks S., Bornmann W., Finn R., Dowd C.S., et al. B cell signaling is regulated by induced palmitoylation of CD81. J Biol Chem 2004, 279:31973-31982.
168. Ravetch J.V., Bolland S. IgG Fc receptors. Annu Rev Immunol 2001, 19:275-290.
169. Bolland S., Pearse R.N., Kurosaki T., Ravetch J.V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998, 8:509-516.
170. Kono H., Kyogoku C., Suzuki T., Tsuchiya N., Honda H., Yamamoto K., et al. FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet 2005, 14:2881-2892.
171. Jenks S.A., Sanz I. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev 2009, 8:209-213.
172. Sohn H.W., Pierce S.K., Tzeng S.J. Live cell imaging reveals that the inhibitory FcγRIIB destabilizes B cell receptor membrane-lipid interactions and blocks immune synapse formation. J Immunol 2008, 180:793-799.
173. Damjanovich S., Vereb G., Schaper A., Jenei A., Matkó J., Starink J.P., et al. Structural hierarchy in the clustering of HLA class I molecules in the plasma membrane of human lymphoblastoid cells. Proc Natl Acad Sci USA 1995, 92:1122-1126.
174. Bodnár A., Jenei A., Bene L., Damjanovich S., Matkó J. Modification of membrane cholesterol level affects expression and clustering of class I HLA molecules at the surface of JY human lymphoblasts. Immunol Lett 1996, 54:221-226.
175. Jenei A., Varga S., Bene L., Mátyus L., Bodnár A., Bacsó Z., et al. HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells. Proc Natl Acad Sci USA 1997, 94:7269-7274.
176. Goebel J., Forrest K., Flynn D., Rao R., Roszman T.L. Lipid rafts, major histocompatibility complex molecules, and immune regulation. Hum Immunol 2002, 63:813-820.
177. Gombos I., Detre C., Vámosi G., Matkó J. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation. Immunol Lett 2004, 92:117-124.
178. Gombos I., Kiss E., Detre C., László G., Matkó J. Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death. Immunol Lett 2006, 104:59-69.
179. Fooksman D.R., Gronvall G.K., Tang Q., Edidin M. Clustering class I MHC modulates sensitivity of T cell recognition. J Immunol 2006, 176:6673-6680.
180. del Real G., Jimenez-Baranda S., Mira E., Lacalle R.A., Lucas P., Gomez-Mouton C., et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 2004, 200:541-547.
181. Ghittoni R., Patrussi L., Pirozzi K., Pellegrini M., Lazzerini P.E., Capecchi P.L., et al. Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. Faseb J 2005, 19:605-607.
182. Hillyard D.Z., Nutt C.D., Thomson J., McDonald K.J., Wan R.K., Cameron A.J., et al. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis 2007, 191:319-325.
183. Escriba P.V. Membrane-lipid therapy: a new approach in molecular medicine. Trends in Molecular Medicine 2006, 12:34-43.
184. Balogh A., Beck Z., Kis A., Izsepi E., Cervenák L., Lászlo G., et al. New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production. J Lipid Res 2010, 51. 10.1194/jlr.M000372.
185. Verma S.P. HIV: a raft-targeting approach for prevention and therapy using plant-derived compounds (review). Curr Drug Targets 2009, 10:51-59.